-+ 0.00%
-+ 0.00%
-+ 0.00%

ALZPATH - ALZPATH AND SIEMENS HEALTHINEERS SIGN LICENSING AGREEMENT TO ADVANCE GLOBAL ACCESS TO BLOOD-BASED ALZHEIMER'S DISEASE DIAGNOSTIC TESTING

Reuters·12/15/2025 13:31:47

Please log in to view news